Pablo Parker

3.7k total citations
51 papers, 2.2k citations indexed

About

Pablo Parker is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pablo Parker has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 14 papers in Oncology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pablo Parker's work include Hematopoietic Stem Cell Transplantation (36 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Pablo Parker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (36 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Pablo Parker collaborates with scholars based in United States, Australia and Singapore. Pablo Parker's co-authors include Stephen J. Forman, Paul J. Martin, Mary E.D. Flowers, Laura Johnston, Frederick R. Appelbaum, Barry E. Storer, David S. Snyder, G. Schmidt, Rainer Storb and Karl G. Blume and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Pablo Parker

51 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Parker United States	25	1.6k	645	520	488	297	51	2.2k
Carrie L. Kitko United States	24	1.6k 1.0×	802 1.2×	449 0.9×	373 0.8×	142 0.5×	94	2.1k
Renate Arnold Germany	25	1.4k 0.8×	696 1.1×	466 0.9×	714 1.5×	80 0.3×	77	2.4k
Jeanne Palmer United States	30	2.0k 1.2×	559 0.9×	605 1.2×	561 1.1×	217 0.7×	153	2.9k
Shelly Carter United States	18	1.5k 0.9×	661 1.0×	433 0.8×	305 0.6×	306 1.0×	25	2.1k
Jean‐Pierre Jouet France	17	1.5k 1.0×	372 0.6×	443 0.9×	379 0.8×	75 0.3×	39	1.9k
Lorentz Brinch Norway	21	1.0k 0.6×	266 0.4×	556 1.1×	242 0.5×	103 0.3×	61	1.7k
Roberta King United States	22	2.1k 1.3×	771 1.2×	470 0.9×	751 1.5×	268 0.9×	41	2.7k
John Horan United States	26	1.5k 0.9×	458 0.7×	296 0.6×	554 1.1×	256 0.9×	87	2.2k
KC Doney United States	15	1.6k 1.0×	422 0.7×	380 0.7×	319 0.7×	124 0.4×	24	1.9k
Wael Saber United States	31	2.7k 1.7×	667 1.0×	869 1.7×	822 1.7×	277 0.9×	173	3.7k

Countries citing papers authored by Pablo Parker

Since Specialization

Citations

This map shows the geographic impact of Pablo Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Parker more than expected).

Fields of papers citing papers by Pablo Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Parker. The network helps show where Pablo Parker may publish in the future.

Co-authorship network of co-authors of Pablo Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Parker. A scholar is included among the top collaborators of Pablo Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Parker. Pablo Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malki, Monzr M. Al, Ketevan Gendzekhadze, Tracey Stiller, et al.. (2019). Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation. Bone Marrow Transplantation. 55(2). 409–418. 8 indexed citations

Malki, Monzr M. Al, Joo Y. Song, Dongyun Yang, et al.. (2017). Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT). Blood. 130. 3212–3212. 2 indexed citations

Malki, Monzr M. Al, Sanjeet Dadwal, Dongyun Yang, et al.. (2017). High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes. Blood. 130. 4494. 7 indexed citations

Theophanous, Christos, John A. Irvine, Pablo Parker, & Gloria B. Chiu. (2015). Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 21(12). 2180–2184. 35 indexed citations

Shayani, Sepideh, Joycelynne Palmer, Tracey Stiller, et al.. (2012). Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis. Biology of Blood and Marrow Transplantation. 19(2). 298–304. 79 indexed citations

Behrendt, Carolyn E., et al.. (2012). Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease. Inflammation. 36(1). 177–185. 29 indexed citations

Nakamura, Ryotaro, Joycelynne Palmer, Margaret O’Donnell, et al.. (2012). Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. Leukemia Research. 36(9). 1152–1156. 25 indexed citations

Sahebi, Firoozeh, Paul Frankel, Len Farol, et al.. (2011). Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 18(3). 486–492. 12 indexed citations

Kikuchi, Takahide, Pablo Parker, Michael C. Wu, et al.. (2007). Use of Fluid-Ventilated, Gas-Permeable Scleral Lens for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 13(9). 1016–1021. 91 indexed citations

10.

Giralt, Sergio, Brent R. Logan, Douglas Rizzo, et al.. (2007). Reduced-Intensity Conditioning for Unrelated Donor Progenitor Cell Transplantation: Long-Term Follow-Up of the First 285 Reported to the National Marrow Donor Program. Biology of Blood and Marrow Transplantation. 13(7). 844–852. 52 indexed citations

11.

Sahebi, Firoozeh, Ricardo Spielberger, Neil Kogut, et al.. (2006). Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. Bone Marrow Transplantation. 37(9). 825–829. 26 indexed citations

12.

Carpenter, Paul A., James N. Lowder, Laura Johnston, et al.. (2005). A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 11(6). 465–471. 53 indexed citations

13.

Nash, Richard A., Laura Johnston, Pablo Parker, et al.. (2005). A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(7). 495–505. 95 indexed citations

14.

Paterson, Amber G., Michelle Riba, Kathleen A. Griffith, et al.. (2002). Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplantation. 29(11). 917–925. 112 indexed citations

15.

Khoury, H. Jean, A. Kashyap, R Brown, et al.. (2001). Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplantation. 27(10). 1059–1064. 88 indexed citations

16.

Nevill, Thomas J., Deborah Marcellus, Pablo Parker, et al.. (2000). Donor leukocyte infusions for multiple myeloma. Bone Marrow Transplantation. 26(11). 1179–1184. 135 indexed citations

17.

Parker, Pablo, Harry Openshaw, & Stephen J. Forman. (1997). Myositis associated with graft-versus-host disease. Current Opinion in Rheumatology. 9(6). 513–519. 26 indexed citations

18.

Stein, Anthony S., Margaret O’Donnell, GM Schmidt, et al.. (1996). In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.. Journal of Clinical Oncology. 14(8). 2206–2216. 46 indexed citations

19.

Chao, Nelson J., G. Schmidt, Joyce C. Niland, et al.. (1993). Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease. New England Journal of Medicine. 329(17). 1225–1230. 211 indexed citations

20.

O'Donnell, M R, AP Nademanee, D. Snyder, et al.. (1987). Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes.. Journal of Clinical Oncology. 5(11). 1822–1826. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact